Navigation Links
Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
Date:8/27/2009

APA article discusses other advanced wound healing approaches for the treatment of diabetic foot ulcers that include bioengineered skin substitutes, as well as medical devices that provide negative pressure wound therapy. Bioengineered skin substitutes represent an important class of products that include two FDA-approved dermal graft substitutes: Apligraf(R) a combination of human fibroblasts and keratinocytes and Dermagraft(R), consisting of human fibroblasts alone. Based on product labeling and usage instructions, both products require multiple grafting procedures by physicians into the wound area (and may require the use of sutures) on a weekly or bi-weekly basis, by physicians over a 12-week period. Some products in this class require low temperature storage (-70 degrees Celsius) or need to be special ordered by a physician immediately prior to patient treatment because of a very limited shelf life (approximately 10 days).

Negative Pressure Wound Therapy - Negative pressure wound therapy for the treatment of diabetic ulcers consists of medical devices employing the use of specialized wound dressings connected to an air supply line linked to a microprocessor-controlled air pump to create a healing environment around the wound. These systems are designed to create a moist wound environment, reduce edema and promote formation and perfusion of granulation tissue. They have been proven to be safe and effective, accommodate a wide range of wound sizes, and are used in a broad range of other types of wounds including surgical as well as trauma wounds. However, effective therapy generally requires that these systems be used by patients on a 24/7 basis for up to 16 weeks (based on recently published studies). As a result, they are complex and challenging for patients to use over extended periods of time, impair patient mobility, and require repeated physician visits, equipment cleansings and dressing changes.

'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
2. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
3. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
4. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
5. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
6. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
7. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
8. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
9. Wyoming Department of Healths Pay-for-Participation Program Reports Positive Clinical Outcomes
10. Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
11. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... MISSISSAUGA, ON , Feb. 27, 2015 /CNW/ - Covalon ... advanced medical technologies company, today announced financial results for ... For the three months ended December 31, 2014, ... for the quarter was $229,820 or $0.02 per share.  ... Pedlar , said "I am very pleased with the ...
(Date:2/27/2015)... , Feb. 27, 2015  Bionik Laboratories Corp. (OTC:DWTPD), ... announced today that it acquired Bionik Laboratories, Inc., a ... completed the sale to qualified accredited investors of units ... gross proceeds of approximately $6.2 million. Shares of the ... the OTC Markets under the symbol "DWTPD" until FINRA,s ...
(Date:2/26/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... the t:slim® and t:flex™ Insulin Pumps, today announced the ... of its common stock at a price to the ... Tandem from this offering are expected to be $56.3 ... estimated offering expenses payable by Tandem. All of the ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... China-based pharmaceutical and biotechnology research and development outsourcing ... main Chinese subsidiary, Shanghai ChemPartner Co. Ltd. ("ChemPartner"), ... Inc.,s ("Charles River") Shanghai research facility. ...
... ® Labeling, part of Newell Rubbermaid,s Technology global ... scanner designed to streamline workflow and assist healthcare facilities ... records (EHR). DYMO CardScan Image Capture ... with EHR or practice management software systems. It delivers ...
Cached Medicine Technology:ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 2DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing 2DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing 3
(Date:3/1/2015)... Chicago, IL (PRWEB) March 01, 2015 Ticket ... Grateful Dead in Chicago at Soldier Field. Deadheads ... was announced in January. , Grateful Dead was formed 50 ... and they were together as one until the untimely death ... known for combining different genres including blues, reggae, rock, bluegrass, ...
(Date:3/1/2015)... 2015 Theme and plugin developers from ... pack for Final Cut Pro X entitled Transccordion. ... to any FCPX editors project.” Said Christiana Austin, CEO ... tools needed to easily drag and drop their accordion ... many different controls over the parameters of this transition ...
(Date:2/28/2015)... 28, 2015 In a recent episode ... of Game Change Athlete Development Services and ... the benefits of athlete development and player engagement during ... unique challenges that athletes face and how off-field activities ... , Fletcher became involved in athlete development issues while ...
(Date:2/28/2015)... February 28, 2015 March—also known ... time to remind ourselves and others that suspected ... Atlantic NeuroSurgical Specialists (ANS). , Concussions are a ... for 75% of TBIs. There are 1.6-3.8 million ... sound benign, but it is a brain injury. ...
(Date:2/28/2015)... 28, 2015 For those people who ... the Mesothelioma Applied Research Foundation (Meso Foundation) ... March 3, starting at 9:30 AM. , The live ... The broadcast can be accessed through any browser on ... , The Symposium is a unique event that covers ...
Breaking Medicine News(10 mins):Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2
... poor oral health diagnosis was a stronger predictor of ... high levels of fibrinogen (a clotting factor), low HDL ... the oral health data of 256 cardiac patients to ... the study show the strongest predictor of coronary disease ...
... and easier way to protect the general population and ... deadly bioterror attack. Scientists have developed a powdered form ... the nose, thus eliminating needle injections. ,The new ... (rPA), a genetically engineered protein. Researchers say the powdered ...
... organs than conventional X-rays. The effective dose delivered during a ... a typical mammogram. A new study shows the risk of ... slightly less than the cancer death risk of atomic bomb ... study also shows elective annual scans carry much higher risks. ...
... shows smokers under age 40 are five-times more likely to ... // all non-fatal heart disease cases of study participants between ... of which were men and 4,047 were women. ,Results ... attack were smokers between the ages of 35 and 39.In ...
... is born with an isolated cleft lip and palate, which means ... birth defects. ,Researchers say they now have a new gene ... child born with a cleft lip and palate one of the ... during early fetal development. ,Researchers identified the gene IRF6 ...
... people consider long, continuous workouts to be beneficial. However, ... a more effective way // to lower fat in ... triglyceride levels. Triglycerides are artery-blocking fats found in the ... the first day, they ate a high-fat meal and ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: